Beckman Coulter to Acquire Siemens Healthcare Diagnostics’ Clinical Microbiology Business
Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.
The Siemens clinical microbiology business is an established leader in microbial identification and antibiotic sensitivity testing (ID/AST). The business operates with an installed base of over 6,000 instruments globally. The microbiology product line includes the MicroScan® Instruments and MicroScan® panels/consumables, along with data management solutions. The MicroScan systems are recognized in their industry for their high accuracy and superior detection of emerging resistance.
Beckman Coulter Diagnostics President Arnd Kaldowski said, "The clinical microbiology business will be an excellent complement to Beckman Coulter's Diagnostics business with a strong reputation and market position. Adding its ID/AST solutions to our existing products and services will create an opportunity to enhance our offerings to laboratory customers and improve patient care. The acquisition expands our product portfolio with differentiated analytical systems and menu that elevate our clinical capabilities for customers, while driving continued growth.” The transaction is expected to close in Q1 2015. The agreement is subject to applicable regulatory approvals and other customary closing conditions.
31.07.2014
